About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >
FDA grants accelerated approval to Biogen treatment for rare form of ALS
Tickers BIIB IONS
Tags BIIB IONS
From MarketWatch
What's Going On With Biogen Stock Tuesday?
Tickers BIIB IONS
Tags Market News why it's moving News
From Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
Tickers BIIB IONS
Tags General Benzinga News
From Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
Tickers ACRS AMRS IONS
Tags Market News NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS Stocks to Sell
From InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
Tickers AZN AZNCF IONS
Tags General AZN Benzinga
From Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Tickers AZN IONS
Tags Recent Press Releases AZN IONS
From Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
Tickers ALNY ARWR IONS MRNA
Tags Health Care Trading Ideas Briefs
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Benzinga BZI/AAR IONS
From Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Tickers AZN AZNCF BXRX IONS
Tags Briefs Health Care Biotech
From Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
Tickers BIIB IONS
Tags Benzinga General News
From Benzinga
Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Tickers ADC AIZ ALLO ALNY
Tags BZI/Ratings ALNY NVDA
From Benzinga
Wall Street predicts approval for another ALS drug
Tickers AMLX BIIB IONS
Tags IONS AMLX BIIB
From MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
Tickers BIIB IONS
Tags News Market News Large Cap
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags IONS Earnings Market News
From Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
Tickers IONS
Tags IONS Briefs Health Care
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
Tickers ARKG EXAS IONS PACB
Tags Cologuard disruptive technology channel ARK Invest
From ETF Trends
The Latest Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags BZI/AAR IONS Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Tickers ADPT AIMC AMV APPN
Tags Intraday Update AIMC Benzinga
From Benzinga
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
Tickers IONS
Tags Benzinga BZI/ROCE Market News
From Benzinga
Gene Deal Adds New Dimension to Biotech ETF SBIO
Tickers ALPS IONS SBIO
Tags ETF Building Blocks Channel SBIO IONS
From ETF Trends
4 Analysts Have This to Say About Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga BZI/AAR IONS
From Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
Tickers HCAT IONS PSX RSKD
Tags Market News News Price Target Changes
From Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
Tickers BAYRY BAYZF IONS
Tags Briefs Health Care BAYRY
From Benzinga
3 Biotech Stocks to Sell in October
Tickers GILD GLPG ILMN IONS
Tags ILMN GLPG GILD
From InvestorPlace
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
Tickers AZN AZNCF IONS
Tags Large Cap Market News why it's moving
From Benzinga
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
Tickers AMLX BIIB IONS
Tags Recent Press Releases BIIB Market News
From Motley Fool
There's 'Outsized' Risk-Reward For This Biotech, Morgan Stanley Says, Predicting Shares Could Grow More Than 30%
Tickers IONS
Tags Large Cap Market News News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Tickers ADCT ALEC ANNX ARVN
Tags WALD PEN IMCR
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.